Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Study population. EVD, Ebola virus disease.

Published byŠtěpánka Ševčíková Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Study population. EVD, Ebola virus disease."— Presentation transcript:

1 FIGURE 1 Study population. EVD, Ebola virus disease.
Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( J Nutr, nxz142, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 2 Initiation times of vitamin A treatment for patients.
Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( J Nutr, nxz142, The content of this slide may be subject to copyright: please see the slide notes for details.

3 FIGURE 3 Observed mortality proportions for all patients
FIGURE 3 Observed mortality proportions for all patients. Sample size for each stratified exposure group annotated on ... FIGURE 3 Observed mortality proportions for all patients. Sample size for each stratified exposure group annotated on bars. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( J Nutr, nxz142, The content of this slide may be subject to copyright: please see the slide notes for details.

4 FIGURE 4 Standardized bias, before and after 1:1 matching of patients not treated with vitamin A within 48 h to ... FIGURE 4 Standardized bias, before and after 1:1 matching of patients not treated with vitamin A within 48 h to patients treated with vitamin A within 48 h. Dashed line represents the commonly used threshold of balance treatment cohorts. ETU, Ebola Treatment Unit. Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( J Nutr, nxz142, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Study population. EVD, Ebola virus disease."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 3 Doctors leaving (Matthews, 2013, p.13.)

Figure 3 Doctors leaving (Matthews, 2013, p.13.)
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.

Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.

Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
RCTs: randomized controlled ...

RCTs: randomized controlled ...

Similar presentations

Ads by Google